Distinct clinical–immunological subtypes define prognostic heterogeneity in anti-U1RNP-positive connective tissue diseases

OBJECTIVE: Anti-U1 ribonucleoprotein (U1RNP) antibody-positive connective tissue diseases (CTDs) exhibit marked clinical heterogeneity that is not adequately captured by conventional diagnostic classifications. This study aimed to identify intrinsic clinical-immunological subtypes and assess their prognostic implications. METHODS: In this single-center retrospective cohort, 358 patients with anti-U1RNP-positive CTDs were analyzed using multiple correspondence analysis and hierarchical clustering. Key discriminative features were identified through least absolute shrinkage and selection operator (LASSO) regression. Peripheral blood lymphocyte subsets were assessed by flow cytometry, and long-term survival was compared using Kaplan-Meier analysis. RESULTS: Clustering analysis identified three clinical-immunological subtypes with significant differences. Cluster 1, the "mild immunological type", was characterized by minimal autoantibody positivity and relatively normal lymphocyte counts, and exhibited the most favorable prognosis. Cluster 2, the "exocrine gland-joint-muscle involvement type", presented with prominent sicca symptoms, arthralgia, elevated creatine kinase (CK), and interstitial lung disease (ILD), and had an intermediate prognosis. Cluster 3, the "severe systemic type", was associated with marked pericarditis, renal injury, multiple autoantibody positivity, and widespread lymphopenia, and had the poorest survival. LASSO analysis highlighted normal T lymphocyte and T follicular helper cell counts for cluster 1, elevated CK and rheumatoid factor for cluster 2, and anti-dsDNA/anti-nucleosome antibodies, elevated D-dimer, and major organ involvement for cluster 3. CONCLUSION: Anti-U1RNP-positive CTDs comprise distinct clinical-immunological subtypes with different clinical features, immune profiles, and prognostic outcomes. Subtype-based stratification may facilitate precision management, particularly for patients with multiple autoantibody positivity and severe lymphopenia who are at high risk of poor prognosis.

Authors

Institutions

Publication Details

Journal
Rheumatology
Published
2026-11-18
DOI
https://doi.org/10.1093/rheumatology/keag386
Primary Topic
Systemic Lupus Erythematosus Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Distinct clinical–immunological subtypes define prognostic heterogeneity in anti-U1RNP-positive connective tissue diseases

Qianyun Xu, Yan Wang, Qi An, Jingyi Zhang et al.
Rheumatology
Systemic Lupus Erythematosus Research
article

Distinct clinical–immunological subtypes define prognostic heterogeneity in anti-U1RNP-positive connective tissue diseases

Qianyun Xu, Yan Wang, Qi An, Jingyi Zhang, Bomiao Ju, Nan Hu, Xiaohong Lv, Di Liu, Lan He, Jing Zhang, Qian Li, Jing Luo, Jing Huang
article en

Abstract

OBJECTIVE: Anti-U1 ribonucleoprotein (U1RNP) antibody-positive connective tissue diseases (CTDs) exhibit marked clinical heterogeneity that is not adequately captured by conventional diagnostic classifications. This study aimed to identify intrinsic clinical-immunological subtypes and assess their prognostic implications. METHODS: In this single-center retrospective cohort, 358 patients with anti-U1RNP-positive CTDs were analyzed using multiple correspondence analysis and hierarchical clustering. Key discriminative features were identified through least absolute shrinkage and selection operator (LASSO) regression. Peripheral blood lymphocyte subsets were assessed by flow cytometry, and long-term survival was compared using Kaplan-Meier analysis. RESULTS: Clustering analysis identified three clinical-immunological subtypes with significant differences. Cluster 1, the "mild immunological type", was characterized by minimal autoantibody positivity and relatively normal lymphocyte counts, and exhibited the most favorable prognosis. Cluster 2, the "exocrine gland-joint-muscle involvement type", presented with prominent sicca symptoms, arthralgia, elevated creatine kinase (CK), and interstitial lung disease (ILD), and had an intermediate prognosis. Cluster 3, the "severe systemic type", was associated with marked pericarditis, renal injury, multiple autoantibody positivity, and widespread lymphopenia, and had the poorest survival. LASSO analysis highlighted normal T lymphocyte and T follicular helper cell counts for cluster 1, elevated CK and rheumatoid factor for cluster 2, and anti-dsDNA/anti-nucleosome antibodies, elevated D-dimer, and major organ involvement for cluster 3. CONCLUSION: Anti-U1RNP-positive CTDs comprise distinct clinical-immunological subtypes with different clinical features, immune profiles, and prognostic outcomes. Subtype-based stratification may facilitate precision management, particularly for patients with multiple autoantibody positivity and severe lymphopenia who are at high risk of poor prognosis.

Rheumatology
First Affiliated Hospital of Xi'an Jiaotong University (CN), Xi'an Jiaotong University (CN)
Systemic Lupus Erythematosus Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon